Ken Griffin Aclarion, Inc. Transaction History

Citadel Advisors LLC

  • $509 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$0.2 - $0.57 $2,090 - $5,957
10,452 Added 60.73%
27,662 $5,000
Q3 2023

Nov 14, 2023
SELL
$0.33 - $0.73 $4,276 - $9,460
-12,960 Reduced 42.96%
17,210 $5,000
Q2 2023

Aug 14, 2023
BUY
$0.59 - $1.32 $17,800 - $39,824
30,170 New
30,170 $20,000

Others Institutions Holding ACON

# of Institutions
2
Shares Held
99.4K
Call Options Held
0
Put Options Held
0
View Full List

About Aclarion, Inc.

ACON Quotes by TradingView
  • Ticker ACON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 7,821,520
  • Market Cap $2.5M
  • Description
  • Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical de...
More about ACON
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email